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Abstract
Background: Decision aids can be used to support shared decision making (SDM). A 
patient- oriented treatment decision aid (DA) was developed for type 2 diabetes but its 
use by general practice staff appeared to be limited.
Objectives: To explore views of practice staff towards SDM and the DA.
Design: A mixed- methods study within the Dutch PORTDA- diab trial.
Setting and participants: Included were 17 practices with staff members who were respon-
sible for routine diabetes care and had worked with the DA, and 209 of their patients.
Methods: Interviews were conducted focusing on applicability, usefulness and feasi-
bility of the DA. Interviews were tape- recorded, transcribed verbatim and subjected to 
content analysis for identifying and classifying views. Patient- reported data about the 
use of the DA were collected. Associations between specific views and use of the DA 
were tested using Pearson point- biserial correlation.
Results: The majority of practice staff expressed positive views towards SDM, which 
was associated with making more use of the DA. Most of the staff expressed that the 
DA stimulated a two- way conversation. By using the DA, several became aware of 
their paternalistic approach. Some staff experienced a conflict with the content of the 
DA, which was associated with making less use of the DA.
Conclusions: The DA was considered useful by practice staff to support SDM. A posi-
tive view towards SDM was a facilitator, whereas experiencing a conflict with the 
content of the DA was a barrier for making use of the DA.
K E Y W O R D S
decision aids, diabetes mellitus type 2, patient-centered care, primary health care, qualitative 
research, shared decision making
1  | INTRODUCTION
An active role of patients with chronic diseases is required to carry out treat-
ment decisions and daily self- management activities.1 A patient- centred 
care approach is advocated by models of chronic care and in diabetes 
guidelines to support patients in their active role.2,3 A key component of 
patient- centred care is shared decision making (SDM), in which patients 
are involved in decision making regarding their own care.4,5 To support 
SDM, decision aids (DA) can be used.6 DAs are designed to supplement 
the interaction between patients and health- care providers by providing 
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evidence- based information and treatment options to patients. Despite 
their potential efficacy, ineffective or a lack of use of DAs is observed in 
practice.7,8 This can be caused by negative views about the content and 
form as well as the perceived usefulness and feasibility to apply the DA 
in routine practice.9 Most research on SDM and the use of DAs in health 
care has been limited to physicians. In many countries, however, general 
practice staff—such as nurse practitioners and physician  assistants—play 
an important role in the management of diabetes and other chronic dis-
eases. The role of nurses in SDM needs further exploration.10
DAs can be used by patients before consulting a health- care pro-
vider or during encounter with the health- care provider. Compared to 
usual care, the use of DAs can induce better informed and values- based 
choices, and improves communication between patient and health- care 
provider.6,11 A DA should be easy to apply in daily practice, since com-
peting demands and time pressure are often reported barriers.9,12 Also, 
health- care providers must have confidence in the content of the DA, 
which should provide balanced and up- to- date information.13,14
Taking these considerations into account and following the recom-
mendations for developing high quality DAs,15 a patient- oriented treat-
ment DA was developed for patients with type 2 diabetes.16 Patients and 
health- care providers were involved in the development of this DA. The 
DA was intended to empower patients for shared goal setting and treat-
ment decision making. Its effects were evaluated in Dutch primary care 
in the PORTDA- diab (Patient Oriented Treatment Decision Aid diabetes) 
trial, finding no evidence of relevant improved patient empowerment.17 
The DA in this study was to be used before and during consultations with 
the diabetes patients by general practice staff. Although most patients 
reported they had received the DA before their encounter, it appeared 
that during the consultation the DA was not used to its full extent.17 This 
should have included discussing the patient’s personal risks and possibil-
ities for risk reduction with the practice staff. Only 46% of the patients 
reported that they had received all these elements as intended. This may 
in part explain why the DA did not improve patient empowerment for 
setting treatment goals in the PORTDA- diab trial.17
The aim of this study is to explore views of the practice staff to-
wards SDM and learn their opinions about the DA in this context. We 
thus want to identify facilitators and barriers for using the DA as in-
tended. These findings can be used to improve further development 
and implementation of DAs to support SDM. We formulated the fol-
lowing research questions:
1. What are the views of the practice staff towards SDM?
2. What are the views of the practice staff about the applicability and 
feasibility of the DA and its usefulness for SDM?
3. Are these views associated with the use of the DA to its full extent?
2  | MATERIALS AND METHODS
2.1 | Design
This mixed- methods study was a substudy conducted within the 
PORTDA- diab trial.17 The PORTDA- diab trial was a pragmatic 
randomized controlled trial to assess the effects of the DA on patient 
empowerment. A patient representative was involved in agreeing the 
research questions, study design, and interpretation of the results of the 
PORTDA- diab trial. Semi- structured interviews were conducted with 
the practice staff at the end of the PORTDA- diab trial in each participat-
ing practice (Figure 1). In addition, patient- reported data were collected 
about having received all the core elements of the DA as intended.
2.2 | Decision aid
The DA intended to empower patients for shared goal setting and 
treatment decision making. The DA presented personalized infor-
mation on risks and treatment for multiple risk factors such as gly-
cosylated haemoglobin, systolic blood pressure, cholesterol and 
smoking. The DA showed treatment effects on complications, in-
cluding myocardial infarction risks. Information about the personal 
risks and potential risk reduction was presented in text and graphs 
(Figure 2). This was automatically generated via the PORTDA- diab 
software from the electronic medical records. Risk information was 
presented in numbers and words using positive and negative framing, 
and including an expression of uncertainty. More detailed information 
about the DA has been published before.16 The practice staff had to 
offer the DA before a routine consultation to consenting patients that 
had been allocated to the intervention group. The same information 
was available to the staff, who were instructed to discuss the informa-
tion with the patients during consultation.
2.3 | Setting and participants
In the PORTDA- diab trial, 18 general practices from the Northern re-
gion of the Netherlands were recruited by telephone. All practices par-
ticipated in a regional diabetes disease management programme and 
have electronic medical record systems that support the use of struc-
tured care protocols. Within each practice, patients were randomized 
to the intervention group receiving the DA or to the control group re-
ceiving usual care. Before the study started, all staff had been offered 
a training course in motivational interviewing and received a training 
session in risk communication when using the DA. In 17 of the prac-
tices, practice staff members were responsible for routine diabetes care 
and had worked with the DA. All 24 staff members who had worked 
with the DA were approached by telephone and agreed to participate 
in the interviews. In one practice, the general practitioner had worked 
with the DA; this practice was not included in the present study, since 
our aim was to explore views of practice staff. Of the 217 patients who 
were randomized to the DA in the 17 practices, 209 completed the 
questionnaire about having received the core elements of the DA.
2.4 | Ethics
The medical ethics committee of the University Medical Centre 
Groningen approved the PORTDA- diab study (NL29042.042.09). The 
trial is registered at the Dutch Trial register (NTR1942) with the acro-
nym PORTDA- diab.
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2.5 | Data collection
Seventeen interviews were conducted by a researcher (male, PhD) at 
the practice offices. Only the researcher and participants were pre-
sent. The researcher had been involved in developing and testing the 
DA. The interviews were held with all staff members who had used 
the DA. In 11 practices this was one staff member. In the other prac-
tices two or three staff members had worked with the DA, who were 
interviewed together. The interview started with general questions 
about the practice organization, and the role and level of autonomy 
of the practice staff in relation to diabetes care. Next, a topic list was 
used to guide the interviews focusing on the applicability, usefulness 
and feasibility of the DA in relation to the patient population, SDM 
and practice organization (Table 1). Also, more general views towards 
the care process and SDM were retrieved. The topic list was based 
on previous evaluations of innovation implementations strategies.18 
Interviews were tape- recorded and transcribed verbatim. The dura-
tion was between one and one and a half hour. No field notes were 
made during or after the interviews.
All participating patients were sent a structured questionnaire to 
report whether they: (i) had received the DA before the consultation, 
(ii) had discussed their risks for complications with the health- care pro-
vider during the consultation, and how these risks could be reduced. 
When patients answered positive to these questions, the DA was con-
sidered to having been used to ‘its full extent’.17
2.6 | Data analysis
We used qualitative content analysis method, which is a stepwise ap-
proach to analyse data content.19 A preliminary coding scheme was 
developed by two researchers with a background in psychology (MSc) 
and medical sociology (FMH, PhD), respectively, after independently 
having read the interviews and highlighted codes. Codes are defined 
as salient or frequently mentioned words, sentences or phrases in the 
text. After discussing the codes and coming to a consensus, a prelimi-
nary coding framework was developed where the codes were placed 
in themes and subthemes. Next, a specialized diabetes nurse (AW, 
MSc) and a communication expert (EdP, MSc) applied and refined the 
coding framework while coding the interviews. All interviews were 
coded by both researchers. Credibility was established by discuss-
ing the framework and coding with a senior researcher (PD, PhD). 
Discrepancies were solved by discussion and consulting the original 
transcript information for verification. All codes were documented at 
practice level, since interviews were conducted per practice.
Next, the results of the qualitative analysis were used to classify 
practices as supporting or not supporting specific views that could be 
considered as facilitators or barriers for using a DA to support SDM. This 
included positive or negative views about involving patients in SDM, 
and positive or negative views about the DA. Opposing views within 
one practice were considered as not supporting a specific view. Pearson 
point- biserial correlation (IBM SPSS Statistics 24) was used to investigate 
F IGURE  1 Flow diagram of study 
participants
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F IGURE  2 Example showing part of the decision aid
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the associations of binary views with the use of the DA to its full extent 
at practice level. The latter was defined as the percentage of patients per 
practice for whom the decision aid was used to its full extent (Table 2).
3  | RESULTS
3.1 | Sample characteristics
In 12 of the 17 participating practices, the practice staff consisted of 
specialized assistants (Table 2). These assistants had received one or 
two years training in conducting protocol- based care for chronic dis-
eases, including diabetes. In four other practices, this care was pro-
vided by general assistants, who had received only informal training 
in diabetes care. In one practice, a diabetes nurse conducted diabetes 
care. Diabetes nurses receive four year general nursing education with 
an additional one year specialized training in protocol- based diabetes 
care. Most practices work with protocols for diabetes care. According 
to this protocol, diabetes patients visit the practice four times per 
year. All of the staff conducted routine diabetes consultations, which 
include physical examination, risk assessment, education and coun-
selling on lifestyle issues. In seven practices, the patients visited the 
general practitioner for the annual consultation. In most practices, the 
staff had to consult the general practitioner in case of clinical prob-
lems and for changes in medication treatment.
3.2 | Views towards shared decision making
Seven themes with 12 major (that is, often mentioned) and 6 minor 
subthemes were identified (Table 3).
3.2.1 | Role of practice staff in SDM
In 14 of 17 practices the staff was in general positive about patient 
participation in decision making and involving patients in conversations 
and deliberations. They saw their role as advisory and aimed for patient 
centeredness. They described that they usually provide information and 
education, talk about benefits and harms of options, and ask what the 
patients want. Some staff members stated that they always leave the 
final choice to the patient, even when the patient chooses to do nothing.
Basically what I say is: This is really our advice but you 
decide for yourself what you want to do or not. … and 
that you sometimes let people make their own choices. 
(Practice 11)
In case of medication decisions, the staff of two practices doubted 
whether they should offer this choice to the patient.
No. I do not know whether you should offer that [drug] 
choice to the patient. Perhaps it is better to make this 
choice for them. (Practice 6)
The staff of the remaining three practices did not express a positive 
view towards involving patients in decision making. One showed a clear 
paternalistic view by stating that as provider you decide for your patients.
Obviously, they are not used to making the decision 
themselves because I, as health-care provider, make 
this decision for them. (Practice 12)
3.2.2 | Role of the patients in SDM
In seven practices, the staff felt that their patients were usually pas-
sive, not willing to decide for themselves, and were inclined to shift 
the responsibility to the health-care provider. Some staff felt that their 
patients were not motivated or willing to make decisions because they 
trivialize the problem.
Then they look at you quizzically, like, what should I do? 
And, yes, no, you know what is best? (Practice 16)
In such cases, patients did not want to discuss it any 
further.. because they downplay it a lot. (Practice 1)
TABLE  1 Topic list for the semi- structured interviews
General aspects Can you explain how diabetes care is organized in 
this practice?
What is your role and responsibility?
What did you think about the decision aid?
Applicability: 
content and 
form
What did you think about the amount of 
information (text and graphs) in the decision aid?
What did you think about the information level 
(degree of difficulty) in the decision aid?
What did you think about the layout of the 
decision aid?
Did you agree with the content of the decision aid?
Did you experience any difficulties with the 
decision aid (technical)?
Usefulness: 
utility and 
value
How did patients react to the decision aid?
Did the decision aid support or hinder the 
conversation with the patients?
Did the decision aid have an effect on the 
patient’s understanding or insight?
Did the decision aid have an effect on your own 
understanding or insight in the patients’ situation?
Was the decision aid applicable for all patients?
Did your work process change as you gained 
more experience with the decision aid?
Feasibility: 
context
Did working with the decision aid fit within a 
routine consultation?
Was it workable to offer the decision aid to the 
patient before the consultation?
Was there an adequate place for patients to work 
with the decision aid prior to the consultation?
Was it feasible to discuss the decision aid 
information with the patient?
Other remarks Do you have any other remarks?
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TABLE  2 Characteristics of the participating practices (n=17)
Practice 
number
Number of 
staff included Profession
Number of 
patients in 
control group
Number of 
patients in 
intervention group
Number of patients 
reporting use of 
decision aid
Percentage of patients 
reporting use of decision 
aid to its full extent
1 1 Specialized assistant 6 13 13 38,5%
2 1 Specialized assistant 7 14 14 42,9%
3 3 Specialized assistants 11 23 23 39,1%
4 1 Specialized assistant 2 4 4 75,0%
5 1 Specialized assistant 7 14 13 46,2%
6 1 Specialized assistant 7 10 10 70,0%
7 2 Specialized assistants 10 16 16 37,5%
8 2 Specialized assistants 12 23 22 63,4%
9 1 Specialized assistant 9 19 18 55,6%
10 2 Specialized assistants 10 18 17 23,5%
11 2 Specialized assistants 9 17 16 62,5%
12 1 Specialized assistant 2 4 2 0,0%
13 2 General assistants 1 4 4 50,0%
14 1 General assistant 6 12 12 41,7%
15 1 General assistant 3 4 3 33,3%
16 1 General assistant 4 8 8 62,5%
17 1 Diabetes nurse 8 14 14 35,7%
TABLE  3 Themes & subthemes for views on shared decision making and decision aid
Theme Subthemes
Views on shared decision 
making
Own role in shared decision making Role is seen as advisory, providing information and education (major)
Positive towards involving patients in decision making (major)
Some decisions must be made by provider (minor)
Patient’s role in shared decision making Patients are not willing or motivated to be involved (major)
Views on decision aid Content and format Amount is adequate and manageable for patients (major)
Clear presentation in text and graphs (major)
Conflict with content, since weight is not included as risk factor (minor)
Conflict with content, since patients are allowed to decide that they did 
not want recommended medication (minor)
Usefulness for provider Aid increases awareness of own directive or paternalistic approach (major)
Aid supports to involve patients in actual shared decision making (major)
Aid is helpful for clarifying risk information (major)
Aid confirms what they already knew (minor)
Usefulness for patient Personalized information is helpful for awareness and motivating patients 
(major)
Small risk reductions are not motivating to do anything (major)
Usefulness for two- way conversation Aid supports dialogue with patients and makes them talk and think for 
themselves (major)
Aid is helpful to structure consultation and prioritize issues (minor)
Feasibility and time Aid fits well in existing practice routines (major)
Extra time is needed to organize and prepare for the consultation (minor)
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3.3 | Views about the decision aid
3.3.1 | Applicability
The amount of information in the DA was considered adequate and 
manageable for patients according to the staff in 11 of the practices. 
In the other practices, there were concerns that for some patients it 
might have been too much information at once. The presented infor-
mation, both the text and graphs, was easy to understand for patients 
according to most staff. A few patients needed explanation about the 
graphs, especially in case of small risk reductions.
In five practices, the staff mentioned that the patient’s weight 
was not included as risk factor in the DA and that they considered 
this as a missed opportunity. For three of them, this led to a conflict 
with the DA since they saw reducing overweight as an important 
target in their population. One other practice experienced a conflict 
with the DA because patients were allowed to decide that they did 
not want medication, whereas the staff felt that some drugs, such as 
statins, were always recommended in patients with type 2 diabetes.
Therefore it frustrated my advice more or less when 
someone had to lose weight. (Practice 10)
3.3.2 | Usefulness
In 14 practices, the staff became more aware of their directive ap-
proach, but also of their assumptions about what patients understand 
or are willing and able to do for themselves. Working with the DA 
supported them in actual SDM. Some realized that they may have put 
patients in a passive role. Several experienced how difficult it was to 
change their approach towards patients.
It made me more conscious of the patient’s responsi-
bility. It was already there but now it became stronger. 
Like: It is your choice, these treatments. (Practice 5)
It is so difficult to let people speak and not assume 
what they want; to let them make their own choices. 
(Practice 7)
The DA was appreciated because it presented personalized informa-
tion clearly laid out for the patients.
I noticed that patients liked it to receive things on paper 
that are applicable only for them. (Practice 2)
The information provided by the DA was considered not that help-
ful when it showed little gain in the patient’s risk reduction. The staff 
in nine practices felt that sometimes the risk reductions were so small 
that it was not motivating for the patients or the staff themselves to 
do anything.
When the risk reduction is low, it does not tell peo-
ple that much. … Also, when somebody was young, 
say below 50, he did not have that much risk anyway 
(Practice 10)
I think in general, yeah, that the risk reduction is disap-
pointing to me. So, in that sense, not that motivating to 
start. (Practice 8)
In eight practices, the staff thought that most of their patients were 
well regulated, except for the ones being overweight. Some staff men-
tioned that the information from the DA confirmed that they did a good 
job, whereas another mentioned that it often did not bring any news. In 
nine practices, the staff mentioned that the DA finally motivated several 
patients to come into action. Some patients perceived the information as 
confronting or became scared by the information.
They suddenly saw something like: Hey, now I am seri-
ously going to think about whether I should quit smok-
ing, because this is actually quite different. (Practice 8)
Yeah, some people did want to start using a certain 
drug or to lower their blood pressure a bit further. 
(Practice 9)
The DA was considered helpful in 13 practices to make patients more 
aware of their condition and their personal risks. The staff also found the 
DA helpful for clarifying risk information.
The decision aid is quite good to make the diabetic 
aware of his own illness and to make them think for 
themselves. (Practice 12)
I could explain it clearly, like, if you are, for example, at 
10%, and by doing this or that you can change this and 
reduce this. (Practice 17)
In 15 practices, the staff expressed that the conversation and two- 
way exchange with the patient had been supported by using the DA. The 
DA also helped to structure the consultation and prioritize issues with 
the patient.
It is also a good way to start a dialogue with patients. 
(Practice 4)
They come forward themselves, it is more initiated by 
the patient, since he sees it. They started talking about 
things, you can nicely discuss it further. (Practice 2)
Like: I’d like to discuss a few things but what do you want 
to discuss and with what shall we start? (Practice 11)
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3.3.3 | Feasibility
Presenting the DA prior to consultation and using the DA during con-
sultation fitted well with the existing practice routines but some of 
the staff mentioned organizational issues. In a few practices it was 
a challenge to find a quiet or private place for the patients to read 
the DA. In five practices, it was mentioned that some extra time was 
needed to organize and prepare things. In two practices, staff re-
ported that they had experienced time pressure during a consultation 
when a patient became concerned or needed more explanation after 
reading the information provided by the DA. Most did not mention 
time constraints during the consultation, and in five cases the staff 
stated that they were positively surprised that it did not take more 
time than usual.
For some patients it led to a lot of questions and when 
they started asking things, I was thinking, yeah, I do not 
have that much time. (Practice 16)
In terms of time, it turned out better than expected,… 
In the beginning I thought: ‘Oh, how much consultation 
time will this take but it turned out well. (Practice 3)
3.4 | Relation with use of the decision aid to its full  
extent
Within practices no opposing views were observed. The percent-
age of patients for whom the DA was used to its full extent was 
on average 46% and ranged from 0% to 75% (Table 2). Practices 
expressing positive views towards involving patients in decision 
making showed a higher use of the DA to its full extent (Table 4). 
A negative view towards the expected willingness of patients 
for SDM was not associated with less extended use of the DA. 
Expressing negative views regarding the content of the DA was as-
sociated with less use of the DA to its full extent. Views about the 
usefulness of the DA or the time needed were not associated with 
the use of the DA (Table 4).
4  | DISCUSSION
We found that the majority of general practice staff in our study 
expressed a positive view towards SDM but that some felt that their 
patients were not willing or motivated to be involved in the decision 
making. Most of the staff had positive views about the usefulness 
of the DA to stimulate actual SDM. On the other hand, some staff 
members experienced a conflict with the content of the DA. On 
average, the DA was used to its full extent in 46% of the patients. 
A positive view towards SDM was associated with making more use 
of the DA as intended, whereas a negative view towards the con-
tent of the DA was associated with making less use of the DA as 
intended.
Skilled staff with a positive attitude, patients willing to participate 
and a context which supports SDM can facilitate the SDM process.20 
The practice staff in general expressed a positive view towards active 
engagement of patients, which is an important element of SDM.21,22 
Some of the staff, however, viewed their patients as passive and not 
willing or motivated to come into action. This pessimism among prac-
tice staff has been observed before, especially in relation to lifestyle 
changes.23 By using the DA, several staff members became aware that 
they were used to taking a directive or paternalistic role, thereby put-
ting patients in a passive role. This is in line with findings from the 
United States, where decisions made in primary care did not reflect a 
high level of SDM.24 SDM is still not routinely implemented in diabetes 
care.25
TABLE  4 Relationship of views with the use of the decision aid to its full extent
Views towards shared decision making and the decision aid
Number of 
practices
Percentage of patients with use 
of decision aid to full extent
Correlation with 
use to full extent P- value
Positive view towards involving patients in decision making Yes 14 50% 0.535 0.027
No 3 25%
Negative view towards expected willingness of patients to 
be involved
Yes 7 46% 0.021 0.937
No 10 45%
Negative view/conflict with content of decision aid Yes 4 25% - 0.641 0.006
No 13 52%
Positive view about usefulness of decision aid for 
health- care provider
Yes 14 46% 0.026 0.921
No 3 42%
Positive view about usefulness of decision aid for patient Yes 13 44% - 0.129 0.622
No 4 50%
Positive view about usefulness of decision aid for two- way 
conversation
Yes 15 48% 0.286 0.266
No 2 32%
Negative view about time needed to organize and prepare 
things
Yes 5 39% - 0.253 0.327
No 12 49%
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Previously, DAs that were developed to support patient involve-
ment in treatment decisions have shown to improve the patients’ de-
cisional comfort.26,28 It was also found that such DAs can increase 
patient involvement in a conversation about medication.26 Also in our 
study, the staff perceived that the DA supported more two- way con-
versation with the patients. Some of the staff noticed that patients 
became more active in terms of involvement and also in taking action. 
It is expected that diabetes patients who are actively involved in de-
cision making are more likely to agree with their provider regarding 
treatment goals and strategies.29 In other cases, patients still wanted 
the health- care provider to decide, which has been recognized as 
‘welcomed paternalism’.30 No specific sociodemographic characteris-
tics were mentioned in relation to getting patients involved in SDM 
or the usefulness of the DA. This is consistent with a recent meta- 
analysis that showed that DAs are effective across diverse sociode-
mographic patient groups.31
Most of the staff was positive about the amount and clarity 
of the information provided by the DA. The DA was developed 
following the recommendations for high quality DAs,15 including 
balanced and up- to- date information.13,14 Several staff members 
mentioned that the personalized information was particularly 
appreciated by the patients. It is important to know how the in-
formation contained in the DA functioned in the conversation.32 
Regarding the content of the information, some of the practice 
staff expressed negative views. Most staff members were trained 
to follow protocol- based care, and some experienced a conflict be-
tween the DA and their protocol- based care. The DA did not show 
the effects of weight reduction since it was based on the UKPDS 
(United Kingdom Prospective Diabetes Study) risk score that does 
not include weight.16 The practice staff, on the other hand, was 
used to discuss lifestyle and weight control with patients that were 
overweight. By not explicitly addressing weight reduction, the DA 
did not support the advice they wanted to give. Also, the DA of-
fered the option of doing nothing, whereas protocol- based care 
may recommend treatment. For health-care providers following 
guidelines it may be difficult to allow patients to make decisions 
based on their own preferences.33 It is important that practice staff 
learn how to integrate patient values and clinical expertise with 
research evidence.20
Some staff seemed surprised or even disappointed about the 
minor risk reductions presented by the DA. It may be that they had 
insufficient knowledge about the risk scores. It has been found that 
specialized nurses overestimate cardiovascular risk.34 Disappointment 
occurred especially when a patient decided to do nothing because of 
the low risk reduction. The question arises to what extent some of the 
practice staff wanted to use the DA as a tool to persuade patients to 
accept protocol- based care instead of making shared decisions. Such 
persuader roles in decision making and DA use have previously been 
identified for physicians.35
In general, the use of the DA fitted well within current practice. 
We did not observe a relation between perceived time constraints 
and the use of the DA. Previous research reported time restric-
tions and other barriers for implementing SDM.9,36 Most research, 
however, was limited to physicians who may have less time for a 
routine consultation than the general practice staff in our study. DAs 
may lead to shorter as well as longer consultations with an estimated 
median of 2.55 minutes longer.6 For practice staff consultations, with 
an average duration 21 minutes, this may be perceived as less prob-
lematic compared with 10 minutes for a physician visit.37 According 
to several staff members, many of the participating patients were 
already well regulated. In such cases, some staff found the DA not 
useful, confirming previous findings.17 Others still perceived the DA 
as helpful because it showed that they were doing it right. So far, not 
much is known about the usefulness of such affirmative feedback in 
diabetes management.
The DA was not used to its full extent in more than half of the 
patients. This problem was also observed in another practice- based 
primary care study, where on average 66% of relevant elements 
were completed by physicians using the treatment DA.26 In clinical 
encounters, DAs become flexible tools used in various ways fitting 
with both the patients’ and health- care providers’ roles in decision 
making.35 We observed that not having positive views about SDM 
was associated with making less use of the DA. Also, having negative 
views about the content of the DA was associated with making less 
use of the DA, which confirms previous findings.7 Furthermore, we 
already established that the DA was less used by the staff in patients 
where little risk reduction was possible.17 Aside from these influ-
ences of the practice staff, patients may also discourage to apply the 
DA because they do not want to participate in decision making.38 
We found that, according to the staff, several patients were not mo-
tivated to become involved. It is therefore important that practice 
staff working with DAs receive training on how to engage patients 
but also to refrain from making assumptions about the patients’ de-
sired role.38
This is a first study in which the views of general practice staff 
about the use of a patient- oriented DA in SDM are investigated. Our 
framework of codes and (sub)themes was carefully built by research-
ers with different backgrounds, and the coding was conducted inde-
pendently by two researchers. The qualitative analysis was validated 
by the senior researcher (PD) by checking the original transcripts. 
Participants did not provide feedback on the findings. In six practices, 
two or three staff members were interviewed together. It is possible 
that the views of some individuals were not fully expressed during 
these small group interviews. Furthermore, since all practices partici-
pated in the PORTDA- diab trial, the views towards SDM and the use 
of a DA may be more positive in comparison to the general population 
of health-care providers. The quantitative analysis was limited by the 
small number of practices.
5  | CONCLUSION
According to the practice staff, the DA stimulated two- way con-
versation with the patients and also activated some of the patients. 
Having a positive view towards SDM appeared to be a facilitator for 
making use of the DA. On the other hand, experiencing a conflict 
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between the content of the DA and the own protocol- based views 
seemed to be a barrier for making use of the DA. More research is 
needed to investigate the extent to which general practice staff has 
the intention and ability to apply SDM, taking protocol deviations 
into account.
ACKNOWLEDGEMENTS
Jaco Voorham conducted the interviews with practice staff. Mathijs 
Dun was involved in developing the preliminary coding scheme.
CONFLICT OF INTEREST
All authors declare no conflicts of interest.
REFERENCES
 1. Powers MA, Bardsley J, Cypress M, et al. Diabetes self- management 
education and support in type 2 diabetes: a joint position statement 
of the american diabetes association, the american association of 
diabetes educators, and the academy of nutrition and dietetics. Clin 
Diabetes. 2016;34:70-80.
 2. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyper-
glycaemia in type 2 diabetes, 2015: a patient- centred approach. up-
date to a position statement of the american diabetes association 
and the european association for the study of diabetes. Diabetologia. 
2015;58:429-442.
 3. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. 
Improving chronic illness care: translating evidence into action. Health 
Aff (Millwood). 2001;20:64-78.
 4. Charles C, Gafni A, Whelan T. Decision- making in the physician- 
patient encounter: revisiting the shared treatment decision- making 
model. Soc Sci Med. 1999;49:651-661.
 5. Stiggelbout AM, Van der Weijden T, De Wit MP, et al. Shared deci-
sion making: really putting patients at the centre of healthcare. BMJ. 
2012;344:e256.
 6. Stacey D, Legare F, Col NF, et al. Decision aids for people facing 
health treatment or screening decisions. Cochrane Database Syst Rev 
2014;(4):CD001431.
 7. Elwyn G, Scholl I, Tietbohl C, et al. “Many miles to go..”: a system-
atic review of the implementation of patient decision support inter-
ventions into routine clinical practice. BMC Med Inform Decis Mak. 
2013;13(Suppl 2):S14.
 8. Wyatt KD, Branda ME, Anderson RT, et al. Peering into the black box: 
a meta- analysis of how clinicians use decision aids during clinical en-
counters. Implement Sci. 2014;9:26.
 9. Legare F, Ratte S, Gravel K, Graham ID. Barriers and facilitators to 
implementing shared decision- making in clinical practice: update of 
a systematic review of health professionals’ perceptions. Patient Educ 
Couns. 2008;73:526-535.
 10. Clark NM, Nelson BW, Valerio MA, Gong ZM, Taylor-Fishwick JC, 
Fletcher M. Consideration of shared decision making in nursing: 
a review of clinicians’ perceptions and interventions. Open Nurs J. 
2009;3:65-75.
 11. Sepucha KR, Borkhoff CM, Lally J, et al. Establishing the effective-
ness of patient decision aids: key constructs and measurement instru-
ments. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S12.
 12. Joseph-Williams N, Elwyn G, Edwards A. Knowledge is not power 
for patients: a systematic review and thematic synthesis of patient- 
reported barriers and facilitators to shared decision making. Patient 
Educ Couns. 2014;94:291-309.
 13. Abhyankar P, Volk RJ, Blumenthal-Barby J, et al. Balancing the presen-
tation of information and options in patient decision aids: an updated 
review. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S6.
 14. Agoritsas T, Heen AF, Brandt L, et al. Decision aids that really promote 
shared decision making: the pace quickens. BMJ. 2015;350:g7624.
 15. Volk RJ, Llewellyn-Thomas H, Stacey D, Elwyn G. Ten years of the in-
ternational patient decision aid standards collaboration: evolution of 
the core dimensions for assessing the quality of patient decision aids. 
BMC Med Inform Decis Mak. 2013;13(Suppl 2):S1.
 16. Denig P, Dun M, Schuling J, Haaijer-Ruskamp FM, Voorham J. The ef-
fect of a patient- oriented treatment decision aid for risk factor man-
agement in patients with diabetes (PORTDA- diab): study protocol for 
a randomised controlled trial. Trials. 2012;13:219.
 17. Denig P, Schuling J, Haaijer-Ruskamp F, Voorham J. Effects of a pa-
tient oriented decision aid for prioritising treatment goals in diabetes: 
pragmatic randomised controlled trial. BMJ. 2014;349:g5651.
 18. Peters MAJ, Harmsen M, Laurant MGH, Wensing M. Ruimte voor ve-
randering? knelpunten en mogelijkheden voor verbeteringen in de patiën-
tenzorg. NijmegenUitgave: Afdeling Kwaliteit van zorg (WOK), UMC 
St Radboud; 2003.
 19. Saldaña J The coding manual for qualitative researchers (second edition). 
ISBN-13: 978-1446247372. London, UK. SAGE Publications Ltd; 2013.
 20. Friesen-Storms JH, Bours GJ, van der Weijden T, Beurskens AJ. 
Shared decision making in chronic care in the context of evidence 
based practice in nursing. Int J Nurs Stud. 2015;52:393-402.
 21. Makoul G, Clayman ML. An integrative model of shared decision mak-
ing in medical encounters. Patient Educ Couns. 2006;60:301-312.
 22. Lewis KB, Stacey D, Squires JE, Carroll S. Shared decision- making 
models acknowledging an interprofessional approach: a theory analy-
sis to inform nursing practice. Res Theory Nurs Pract. 2016;30:26-43.
 23. Jallinoja P, Absetz P, Kuronen R, et al. The dilemma of patient respon-
sibility for lifestyle change: perceptions among primary care physi-
cians and nurses. Scand J Prim Health Care. 2007;25:244-249.
 24. Fowler FJ Jr, Gerstein BS, Barry MJ. How patient centered are 
medical decisions?: results of a national survey. JAMA Intern Med. 
2013;173:1215-1221.
 25. Rodriguez-Gutierrez R, Gionfriddo MR, Ospina NS, et al. Shared de-
cision making in endocrinology: present and future directions. Lancet 
Diabetes Endocrinol. 2016;4:706-716.
 26. Branda ME, LeBlanc A, Shah ND, et al. Shared decision making for 
patients with type 2 diabetes: a randomized trial in primary care. BMC 
Health Serv Res. 2013;13:301.
 27. Mann DM, Ponieman D, Montori VM, et al. The Statin Choice de-
cision aid in primary care: a randomized trial. Patient Educ Couns. 
2010;80:138-140.
 28. Mullan RJ, Montori VM, Shah ND, et al. The diabetes mellitus med-
ication choice decision aid: a randomized trial. Arch Intern Med. 
2009;169:1560-1568.
 29. Heisler M, Vijan S, Anderson RM, Ubel PA, Bernstein SJ, Hofer TP. 
When do patients and their physicians agree on diabetes treatment 
goals and strategies, and what difference does it make? J Gen Intern 
Med. 2003;18:893-902.
 30. Moser A, van der Bruggen H, Widdershoven G. Competency in shap-
ing one’s life: autonomy of people with type 2 diabetes mellitus in 
a nurse- led, shared- care setting; a qualitative study. Int J Nurs Stud. 
2006;43:417-427.
 31. Coylewright M, Branda M, Inselman JW, et al. Impact of sociode-
mographic patient characteristics on the efficacy of decision AIDS: 
a patient- level meta- analysis of 7 randomized trials. Circ Cardiovasc 
Qual Outcomes. 2014;7:360-367.
 32. Hargraves I, Montori VM. Decision aids, empowerment, and shared 
decision making. BMJ. 2014;349:g5811.
 33. Montori VM, Brito JP, Murad MH. The optimal practice of evidence- 
based medicine: incorporating patient preferences in practice guide-
lines. JAMA. 2013;310:2503-2504.
74  |     WILDEBOER Et aL.
 34. Scholte op Reimer WJ, Moons P, De Geest S, et al. Cardiovascular 
risk estimation by professionally active cardiovascular nurses: 
results from the basel 2005 nurses cohort. Eur J Cardiovasc Nurs. 
2006;5:258-263.
 35. Tiedje K, Shippee ND, Johnson AM, et al. ‘They leave at least believ-
ing they had a part in the discussion’: understanding decision aid use 
and patient- clinician decision- making through qualitative research. 
Patient Educ Couns. 2013;93:86-94.
 36. Legare F, Thompson-Leduc P. Twelve myths about shared decision 
making. Patient Educ Couns. 2014;96:281-286.
 37. Houweling ST, Kleefstra N, van Hateren KJ, et al. Can diabetes man-
agement be safely transferred to practice nurses in a primary care set-
ting? A randomised controlled trial. J Clin Nurs. 2011;20:1264-1272.
 38. Politi MC, Dizon DS, Frosch DL, et al. Importance of clarifying pa-
tients’ desired role in shared decision making to match their level of 
engagement with their preferences. BMJ. 2013;347:f7066.
How to cite this article: Wildeboer A, du Pon E, Schuling J, 
Haaijer-Ruskamp FM, Denig P. Views of general practice staff 
about the use of a patient- oriented treatment decision aid in 
shared decision making for patients with type 2 diabetes: A 
mixed- methods study. Health Expect. 2018;21:64–74.  
https://doi.org/10.1111/hex.12586
